- Home
- QUIK vs ONCY Comparison
QUIK vs ONCY Comparison
Compare QUIK & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QUIK | ONCY |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 106.1M |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | QUIK | ONCY |
|---|---|---|
| Price | $6.10 | $0.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $11.30 | $6.00 |
| AVG Volume (30 Days) | 111.1K | ★ 695.5K |
| Earning Date | 11-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,178,999.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $73.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.26 | $0.33 |
| 52 Week High | $13.36 | $1.51 |
Technical Indicators
Market Signals| Indicator | QUIK | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 41.38 |
| Support Level | $6.12 | $0.94 |
| Resistance Level | $6.80 | $1.04 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 28.22 | 41.68 |
Price Performance
Historical ComparisonAbout QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.